|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Related Content
Trending on PharmExec
1
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
2
How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026
3
Traditional Healthcare Has a Retention Problem It Refuses to Diagnose
4
Novartis to Acquire Myricx Bio for $1.1 Billion
5